SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 129.61 |
Enterprise Value ($M) | 80.06 |
Book Value ($M) | 58.02 |
Book Value / Share | 1.05 |
Price / Book | 2.23 |
NCAV ($M) | -77.91 |
NCAV / Share | -1.41 |
Price / NCAV | -1.66 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.52 |
Return on Assets (ROA) | -0.62 |
Return on Equity (ROE) | -0.79 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.55 |
Current Ratio | 2.55 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 68.44 |
Assets | 204.37 |
Liabilities | 146.35 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 3.09 |
Operating Income | -100.26 |
Net Income | -97.43 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -91.51 |
Cash from Investing | 47.52 |
Cash from Financing | 41.82 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Fmr Llc | 10.68 | 11.39 | |
13G/A | HarbourVest Partners L.P. | 6.40 | 32.68 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
47,332 | 81,831 | 57.84 | |
67,723 | 65,919 | 102.74 | |
86,837 | 51,173 | 169.69 | |
61,442 | 117,901 | 52.11 | |
37,004 | 65,218 | 56.74 | |
(click for more detail) |
Similar Companies | |
---|---|
NXTC – NextCure, Inc. | OGI – Organigram Holdings Inc. |
OLMA – Olema Pharmaceuticals, Inc. | OPK – OPKO Health, Inc. |
OPTN – OptiNose, Inc. |
Financial data and stock pages provided by
Fintel.io